Hydroxocobalamin Dosing for Cyanide Toxicity
Introduction to Hydroxocobalamin Treatment
- The American Heart Association recommends hydroxocobalamin as the primary antidote for cyanide poisoning because it does not cause hypotension or impair oxygen-carrying capacity, which is critical in cases of smoke inhalation with potential carbon monoxide co-poisoning 2, 7
Adult Dosing
- For adults with suspected cyanide poisoning, administer 5 g of hydroxocobalamin IV, increasing to 10 g for cardiac arrest 1, 2
- Standard dose: 5 g IV for suspected cyanide poisoning with severe manifestations (cardiac or respiratory arrest, shock, coma) 1, 3
- Cardiac arrest dose: 10 g IV when the patient is in cardiac arrest from cyanide toxicity 1, 4
Pediatric Dosing
- For children with moderate to severe cyanide poisoning, administer 70 mg/kg IV of hydroxocobalamin (maximum 5 g) 1, 3, 5
Administration Details
- Infuse the initial 5 g dose of hydroxocobalamin over 15 minutes 2
- Consider plasma lactate levels to guide treatment: lactate ≥8 mmol/L in pure cyanide poisoning or ≥10 mmol/L in fire victims without severe burns suggests significant cyanide toxicity 1
Adjunctive Therapy
- Add sodium thiosulfate 12.5 g IV for adults (250 mg/kg for children) following hydroxocobalamin to enhance cyanide elimination 2, 6
- Administer 100% oxygen concurrently, as it accelerates carboxyhemoglobin elimination and counteracts cyanide's mitochondrial effects 2, 6
Important Considerations
- Hydroxocobalamin can cause oxalate nephropathy; monitor renal function 1, 3
- Do not delay treatment for laboratory confirmation; clinical suspicion (fire exposure, altered mental status, metabolic acidosis, elevated lactate) warrants empiric administration of hydroxocobalamin 1
- Administer hydroxocobalamin when patients present with smoke inhalation plus cardiovascular collapse, shock, or coma 1, 3
- Administer hydroxocobalamin in cases of cardiac or respiratory arrest in fire victims 1, 4
- Depressed mental status, seizures, or neurological deterioration are indications for hydroxocobalamin administration 2, 7